These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 19132791)

  • 1. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T; Pope JE
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S; Pope J; ; Baron M
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
    Colangelo KJ; Pope JE; Peschken C
    J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep, and Health Assessment Questionnaire.
    Wheaton L; Pope J
    J Rheumatol; 2010 Apr; 37(4):816-22. PubMed ID: 20110516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.
    Wolfe F; Michaud K; Pincus T
    J Rheumatol; 2005 Jul; 32(7):1261-6. PubMed ID: 15996062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ Are Associated with and Predicted by Different Factors in Rheumatoid Arthritis.
    Verstappen SM; Jacobs JW; Huisman AM; van Rijthoven AW; Sokka T; Bijlsma JW
    J Rheumatol; 2007 Sep; 34(9):1837-40. PubMed ID: 17787050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis.
    Rohekar G; Pope J
    J Rheumatol; 2009 Oct; 36(10):2178-82. PubMed ID: 19755617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
    Sultan N; Pope JE; Clements PJ;
    Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health.
    Kievit W; Welsing PM; Adang EM; Eijsbouts AM; Krabbe PF; van Riel PL
    Arthritis Rheum; 2006 Oct; 55(5):745-50. PubMed ID: 17013821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
    J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain.
    Taal E; Rasker JJ; Riemsma RP
    Ann Rheum Dis; 2004 Dec; 63(12):1655-8. PubMed ID: 15547091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
    Strand V; Scott DL; Emery P; Kalden JR; Smolen JS; Cannon GW; Tugwell P; Crawford B;
    J Rheumatol; 2005 Apr; 32(4):590-601. PubMed ID: 15801012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of gold treatment effect in clinical practice: evidence for effectiveness of intramuscular gold therapy.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1993 May; 20(5):797-802. PubMed ID: 8336305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
    Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
    Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.